The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Dendritic cell–expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice
Open accessAbstract
Most treatments that prevent autoimmune diabetes in nonobese diabetic (NOD) mice require intervention at early pathogenic stages, when insulitis is first developing. We tested whether dendritic cell (DC)–expanded, islet antigen–specific CD4+ CD25+ suppressor T cells could treat diabetes at later stages of disease, when most of the insulin-producing islet β cells had been destroyed by infiltrating lymphocytes. CD4+ CD25+ CD62L+ regulatory T cells (T reg cells) from BDC2.5 T cell receptor transgenic mice were expanded with antigen-pulsed DCs and IL-2, and were then injected into NOD mice. A single dose of as few as 5 × 104 of these islet-specific T reg cells blocked diabetes development in prediabetic 13-wk-old NOD mice. The T reg cells also induced long-lasting reversal of hyperglycemia in 50% of mice in which overt diabetes had developed. Successfully treated diabetic mice had similar responses to glucose challenge compared with nondiabetic NOD mice. The successfully treated mice retained diabetogenic T cells, but also had substantially increased Foxp3+ cells in draining pancreatic lymph nodes. However, these Foxp3+ cells were derived from the recipient mice and not the injected T reg cells, suggesting a role for endogenous T reg cells in maintaining tolerance after treatment. Therefore, inoculation of DC-expanded, antigen-specific suppressor T cells has considerable efficacy in ameliorating ongoing diabetes in NOD mice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
The Role of Tumoral FOXP3 on Cell Proliferation, Migration, and Invasion in Gastric Cancer
Zhang, L., Xu, J., Zhang, X., Zhang, Y., Wang, L., Huang, X., & Xu, Z. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479442 · Cited by 4,088
Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus
Herold, K. C., Hagopian, W., Auger, J. A., Poumian-Ruiz, E., Taylor, L., Donaldson, D., Gitelman, S. E., Harlan, D. M., Xu, D., Zivin, R. A., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012864 · Cited by 1,222
In Vitro–expanded Antigen-specific Regulatory T Cells Suppress Autoimmune Diabetes
Tang, Q., Henriksen, K. J., Bi, M., Finger, E. B., Szot, G., Ye, J., Masteller, E. L., McDevitt, H., Bonyhadi, M., & Bluestone, J. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040139 · Cited by 1,221
Xu, G., Stoffers, D. A., Habener, J. F., & Bonner-Weir, S. (1999) · Diabetes · doi:10.2337/diabetes.48.12.2270 · Cited by 1,209
Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes
Keymeulen, B., Vandemeulebroucke, E., Ziegler, A. G., Mathieu, C., Kaufman, L., Hale, G., Gorus, F., Goldman, M., Walter, M., Candon, S., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043980 · Cited by 1,099
Cutting Edge: Cure of Colitis by CD4+CD25+ Regulatory T Cells
Mottet, C., Uhlig, H. H., & Powrie, F. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.8.3939 · Cited by 927
Mojsov, S., Weir, G. C., & Habener, J. F. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112855 · Cited by 882
Self-citationGutniak, M., Ørkov, C., Holst, J. J., Ahrén, B., & Efendić, S. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205143262003 · Cited by 868
Direct Expansion of Functional CD25+ CD4+ Regulatory T Cells by Antigen-processing Dendritic Cells
Yamazaki, S., Iyoda, T., Tarbell, K., Olson, K., Velinzon, K., Inaba, K., & Steinman, R. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030422 · Cited by 865
Self-citationDeacon, C. F., Johnsen, A. H., & Holst, J. J. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.3.7883856 · Cited by 792
Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice
Tang, Q., Adams, J. Y., Tooley, A. J., Bi, M., Fife, B. T., Serra, P., Santamaria, P., Locksley, R. M., Krummel, M. F., & Bluestone, J. A. (2006) · Nature Immunology · doi:10.1038/ni1289 · Cited by 774
Tarbell, K. V., Yamazaki, S., Olson, K., Toy, P., & Steinman, R. M. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040180 · Cited by 738
Self-citationFollowing a diabetogenic T cell from genesis through pathogenesis
Katz, J. D., Wang, B., Haskins, K., Benoist, C., & Mathis, D. (1993) · Cell · doi:10.1016/0092-8674(93)90730-e · Cited by 696
Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice.
Chatenoud, L., Thervet, E., Primo, J., & Bach, J. F. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.1.123 · Cited by 664
Zheng, S. G., Wang, J. H., Gray, J. D., Soucier, H., & Horwitz, D. A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.9.5213 · Cited by 652
Glucagon-like Peptide-1 Receptor Signaling Modulates β Cell Apoptosis
Li, Y., Hansotia, T., Yusta, B., Ris, F., Halban, P. A., & Drucker, D. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209423200 · Cited by 589
McGeachy, M. J., Stephens, L. A., & Anderton, S. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.5.3025 · Cited by 556
Peng, Y., Laouar, Y., Li, M. O., Green, E. A., & Flavell, R. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400810101 · Cited by 416
Cobbold, S. P., Castejon, R., Adams, E., Zelenika, D., Graca, L., Humm, S., & Waldmann, H. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.10.6003 · Cited by 410
Höglund, P., Mintern, J., Waltzinger, C., Heath, W., Benoist, C., & Mathis, D. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.2.331 · Cited by 409
Szanya, V., Ermann, J., Taylor, C., Holness, C., & Fathman, C. G. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.5.2461 · Cited by 373
Turley, S., Poirot, L., Hattori, M., Benoist, C., & Mathis, D. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030966 · Cited by 347
Bisikirska, B., Colgan, J., Luban, J., Bluestone, J. A., & Herold, K. C. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23961 · Cited by 339
Checkpoints in the progression of autoimmune disease: lessons from diabetes models.
André, I., Gonzalez, A., Wang, B., Katz, J., Benoist, C., & Mathis, D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.6.2260 · Cited by 337
A Comprehensive Review of Interventions in the NOD Mouse and Implications for Translation
Shoda, L. K. M., Young, D. L., Ramanujan, S., Whiting, C. C., Atkinson, M. A., Bluestone, J. A., Eisenbarth, G. S., Mathis, D., Rossini, A. A., Campbell, S. E., et al. (2005) · Immunity · doi:10.1016/j.immuni.2005.08.002 · Cited by 317
Bresson, D. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27191 · Cited by 293
CD4+CD25+ Regulatory T Cells Cure Murine Colitis: The Role of IL-10, TGF-β, and CTLA4
Liu, H., Hu, B., Xu, D., & Liew, F. Y. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.5012 · Cited by 293
Insulinotropic Action of Glucagonlike Peptide-I-(7–37) in Diabetic and Nondiabetic Subjects
Nathan, D. M., Schreiber, E., Fogel, H., Mojsov, S., & Habener, J. F. (1992) · Diabetes Care · doi:10.2337/diacare.15.2.270 · Cited by 289
Self-citationMasteller, E. L., Warner, M. R., Tang, Q., Tarbell, K. V., McDevitt, H., & Bluestone, J. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.5.3053 · Cited by 260
Self-citationAchenbach, P., Koczwara, K., Knopff, A., Naserke, H., Ziegler, A.-G., & Bonifacio, E. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421307 · Cited by 239
Dynamics of Pathogenic and Suppressor T Cells in Autoimmune Diabetes Development
Gregori, S., Giarratana, N., Smiroldo, S., & Adorini, L. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.8.4040 · Cited by 236
Antigen-Specific FoxP3-Transduced T-Cells Can Control Established Type 1 Diabetes
Jaeckel, E., von Boehmer, H., & Manns, M. P. (2005) · Diabetes · doi:10.2337/diabetes.54.2.306 · Cited by 232
Pop, S. M., Wong, C. P., Culton, D. A., Clarke, S. H., & Tisch, R. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042398 · Cited by 210
GLP‐1 receptor agonists are growth and differentiation factors for pancreatic islet beta cells
Egan, J. M., Bulotta, A., Hui, H., & Perfetti, R. (2003) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.357 · Cited by 209
Judkowski, V., Pinilla, C., Schroder, K., Tucker, L., Sarvetnick, N., & Wilson, D. B. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.2.908 · Cited by 206
Yamazaki, S., Patel, M., Harper, A., Bonito, A., Fukuyama, H., Pack, M., Tarbell, K. V., Talmor, M., Ravetch, J. V., Inaba, K., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510606103 · Cited by 184
Self-citationSamy, E. T., Parker, L. A., Sharp, C. P., & Tung, K. S. K. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041033 · Cited by 181
Infectious tolerance and the long-term acceptance of transplanted tissue
Waldmann, H., Adams, E., Fairchild, P., & Cobbold, S. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00406.x · Cited by 177
Cure of Overt Diabetes in NOD Mice by Transient Treatment With Anti-Lymphocyte Serum and Exendin-4
Ogawa, N., List, J. F., Habener, J. F., & Maki, T. (2004) · Diabetes · doi:10.2337/diabetes.53.7.1700 · Cited by 155
Rooman, I., & Bouwens, L. (2004) · Diabetologia · doi:10.1007/s00125-003-1287-1 · Cited by 153
The stages of type 1A diabetes: 2005
Gianani, R., & Eisenbarth, G. S. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00248.x · Cited by 129
Pancreatic Islet Transplantation
Naftanel, M. A., & Harlan, D. M. (2004) · PLoS Medicine · doi:10.1371/journal.pmed.0010058 · Cited by 120
Brand, S. J., Tågerud, S., Lambert, P., Magil, S. G., Tatarkiewicz, K., Doiron, K., & Yan, Y. (2002) · Pharmacology & Toxicology · doi:10.1034/j.1600-0773.2002.910621.x · Cited by 103
You, S., Slehoffer, G., Barriot, S., Bach, J., & Chatenoud, L. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404870101 · Cited by 92
T-Cell Compartments of Prediabetic NOD Mice
Berzins, S. P., Venanzi, E. S., Benoist, C. O., & Mathis, D. J. (2003) · Diabetes · doi:10.2337/diabetes.52.2.327 · Cited by 82
Luo, X., Yang, H., Kim, I. S., Hilaire, F. S., Thomas, D. A., De, B. P., Özkaynak, E., Muthukumar, T., Hancock, W. W., Crystal, R. G., et al. (2005) · Transplantation · doi:10.1097/01.tp.0000161223.54452.a2 · Cited by 80
Self-citationGlucose Homeostasis in the Nonobese Diabetic Mouse at the Prediabetic Stage
Amrani, A., Durant, S., Throsby, M., Coulaud, J., Dardenne, M., & Homo‐Delarche, F. (1998) · Endocrinology · doi:10.1210/endo.139.3.5823 · Cited by 71
Combined treatment with lisofylline and exendin-4 reverses autoimmune diabetes
Yang, Z., Chen, M., Carter, J. D., Nunemaker, C. S., Garmey, J. C., Kimble, S. D., & Nadler, J. L. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.03.177 · Cited by 50
Hori, S., Haury, M., Lafaille, J. J., Demengeot, J., & Coutinho, A. (2002) · European Journal of Immunology · Cited by 46
Couper, J., Hudson, I. L., Werther, G. A., Warne, G. L., Court, J. M., & Harrison, L. C. (1991) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(91)90135-z · Cited by 36
Cited by
Taking dendritic cells into medicine
Steinman, R. M., & Banchereau, J. (2007) · Nature · doi:10.1038/nature06175 · Cited by 2,127
Self-citationInterleukin-2 and Regulatory T Cells in Graft-versus-Host Disease
Koreth, J., Matsuoka, K.-I., Kim, H. T., McDonough, S. M., Bindra, B., Alyea, E. P., Armand, P., Cutler, C., Ho, V. T., Treister, N. S., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1108188 · Cited by 1,119
The Foxp3+ regulatory T cell: a jack of all trades, master of regulation
Tang, Q., & Bluestone, J. A. (2008) · Nature Immunology · doi:10.1038/ni1572 · Cited by 1,031
Dendritic-Cell-Based Therapeutic Cancer Vaccines
Palucka, K., & Banchereau, J. (2013) · Immunity · doi:10.1016/j.immuni.2013.07.004 · Cited by 869
Dendritic cells and cytokines in human inflammatory and autoimmune diseases
BLANCO, P., PALUCKA, A., PASCUAL, V, & BANCHEREAU, J. (2008) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2007.10.004 · Cited by 566
Metadata
- Authors
- Tarbell, K. V., Petit, L., Zuo, X., Toy, P., Luo, X., Mqadmi, A., Yang, H., Suthanthiran, M., Mojsov, S., & Steinman, R. M.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2007-01-08
- Volume
- 204
- Issue
- 1
- Pages
- 191-201
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2153716166
- Cited by
- 342
- References
- 51
- FWCI
- 22.44
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.